| abstract |
A method for the treatment of cognitive and behavioral disorders associated with aging and with dementia syndromes, for example senile dementia, Alzheimer's type, by administering a 2-amino-4-morpholino-6-propyl-1,3,5-triazine of the formula <IMAGE> in which R1=hydrogen, alkyl, aralkyl or acetyl, R2=hydrogen, hydroxyl, alkyl, hydroxyalkyl, alkoxyalkyl, dialkylamino, aryl-hydroxyalkyl, (hydroxycycloalkyl)alkyl, alkanoyloxyalkyl, benzoyloxyalkyl, phenylacetyloxyalkyl, aminocarbonyloxyalkyl, COR3, where R3=alkyl, aryl, halogenoaryl, alkylaryl, alkoxyaryl, aralkyl or aryloxy, CONR4R5, where R4 and R5=hydrogen or alkyl, or R1 and R2 form an alkyleneimino substituted by hydroxyalkyl, and in addition when R1=acetyl, R2=acetoxyalkyl, or a salt thereof. |